The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre, assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the ...

Patients could proceed with intensification if there was no evidence of disease progression after doxorubicin and they had insurance approval or financial capability. Adequate hematopoietic stem cell ...

On this basis we conducted a randomised trial in patients not considered suitable for intensive therapy, comparing clofarabine at a daily dose of 20 mg/m 2 for five consecutive days, with low-dose ara ...

Immunosuppressive Therapy for Patients With Myelodysplastic Syndrome: A Prospective Randomized Multicenter Phase III Trial Comparing Antithymocyte Globulin Plus Cyclosporine With Best Supportive ...

Please provide your email address to receive an email when new articles are posted on . Identification of minimal residual disease using multiparameter flow cytometry following the first treatment ...

Pazopanib versus paclitaxel in relapsed urothelial tumors: A randomized phase II study investigating pazopanib versus weekly paclitaxel in relapsed or progressive transitional cell carcinoma of the ...